应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CTNM Contineum Therapeutics, INC.
盘后交易 01-06 19:12:11 EST
14.22
-0.30
-2.07%
盘后
14.50
+0.28
+1.97%
16:03 EST
最高
15.25
最低
14.15
成交量
6.06万
今开
14.40
昨收
14.52
日振幅
7.58%
总市值
3.67亿
流通市值
1.87亿
总股本
2,578万
成交额
86.86万
换手率
0.46%
流通股本
1,313万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Contineum Therapeutics, Inc.盘中异动 早盘大幅上涨5.03%报15.25美元
市场透视 · 01-06 22:32
Contineum Therapeutics, Inc.盘中异动 早盘大幅上涨5.03%报15.25美元
Contineum Therapeutics, Inc.盘中异动 早盘股价大跌5.07%
市场透视 · 2024-12-13
Contineum Therapeutics, Inc.盘中异动 早盘股价大跌5.07%
Contineum Therapeutics, Inc.盘中异动 股价大跌5.42%报14.32美元
市场透视 · 2024-12-04
Contineum Therapeutics, Inc.盘中异动 股价大跌5.42%报14.32美元
Contineum Therapeutics, Inc.盘中异动 早盘急速拉升5.25%
市场透视 · 2024-11-25
Contineum Therapeutics, Inc.盘中异动 早盘急速拉升5.25%
Contineum Therapeutics, Inc.盘中异动 早盘股价大跌5.35%报16.29美元
市场透视 · 2024-11-18
Contineum Therapeutics, Inc.盘中异动 早盘股价大跌5.35%报16.29美元
Contineum Therapeutics, Inc.盘中异动 股价大跌5.88%
市场透视 · 2024-11-14
Contineum Therapeutics, Inc.盘中异动 股价大跌5.88%
Contineum Therapeutics, Inc.盘中异动 下午盘快速上涨5.19%
市场透视 · 2024-11-08
Contineum Therapeutics, Inc.盘中异动 下午盘快速上涨5.19%
美国研究综述-BXP、Hubspot、高通公司
路透中文 · 2024-11-07
美国研究综述-BXP、Hubspot、高通公司
Contineum Therapeutics, Inc.盘中异动 早盘股价大涨5.12%
市场透视 · 2024-11-06
Contineum Therapeutics, Inc.盘中异动 早盘股价大涨5.12%
美国研究综述-加拉帕戈斯, 马什和麦克莱南, 旅行者
Reuters · 2024-10-22
美国研究综述-加拉帕戈斯, 马什和麦克莱南, 旅行者
Contineum Therapeutics, Inc.盘中异动 下午盘大幅下跌5.42%报16.24美元
市场透视 · 2024-10-10
Contineum Therapeutics, Inc.盘中异动 下午盘大幅下跌5.42%报16.24美元
Contineum Therapeutics, Inc.盘中异动 快速跳水5.08%报16.74美元
市场透视 · 2024-10-04
Contineum Therapeutics, Inc.盘中异动 快速跳水5.08%报16.74美元
美国研究综述-Agenus、Guardant Health、Zoetis
Reuters · 2024-08-14
美国研究综述-Agenus、Guardant Health、Zoetis
公司概况
公司名称:
Contineum Therapeutics, INC.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Contineum Therapeutics, Inc.于2009年作为Versense Pharmaceuticals, Inc. (Versense)在特拉华州注册成立。2023年11月,公司更名为Contineum Therapeutics, Inc. 该公司是一家临床阶段的生物制药公司,专注于发现和开发具有高未满足需求的NI&I适应症的新型口服小分子疗法。他们针对与特定临床损伤相关的生物学途径,他们认为这些途径一旦得到调节,将明显改变疾病的进程。
发行价格:
--
{"stockData":{"symbol":"CTNM","market":"US","secType":"STK","nameCN":"Contineum Therapeutics, INC.","latestPrice":14.22,"timestamp":1736197200000,"preClose":14.52,"halted":0,"volume":60594,"hourTrading":{"tag":"盘后","latestPrice":14.5,"preClose":14.22,"latestTime":"16:03 EST","volume":1410,"amount":20050.48059,"timestamp":1736197390297},"delay":0,"floatShares":13129779,"shares":25777793,"eps":-2.144147,"marketStatus":"盘后交易","change":-0.3,"latestTime":"01-06 19:12:11 EST","open":14.4,"high":15.25,"low":14.15,"amount":868644.135714,"amplitude":0.075758,"askPrice":17.42,"askSize":100,"bidPrice":5.76,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.144147,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1736211600000},"marketStatusCode":4,"adr":0,"listingDate":1712289600000,"exchange":"NASDAQ","adjPreClose":14.52,"preHourTrading":{"tag":"盘前","latestPrice":14.14,"preClose":14.52,"latestTime":"09:06 EST","volume":529,"amount":7393.340501000001,"timestamp":1736172373277},"postHourTrading":{"tag":"盘后","latestPrice":14.5,"preClose":14.22,"latestTime":"16:03 EST","volume":1410,"amount":20050.48059,"timestamp":1736197390297},"volumeRatio":0.830442},"requestUrl":"/m/hq/s/CTNM/wiki","defaultTab":"wiki","newsList":[{"id":"2501230166","title":"Contineum Therapeutics, Inc.盘中异动 早盘大幅上涨5.03%报15.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501230166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501230166?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:32","pubTimestamp":1736173959,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时32分,Contineum Therapeutics, Inc.股票出现波动,股价急速上涨5.03%。截至发稿,该股报15.25美元/股,成交量2125股,换手率0.01%,振幅0.00%。Contineum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.24%。Contineum Therapeutics, Inc.公司简介:Contineum Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现和开发新型口服小分子疗法,用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223239a217966b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223239a217966b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CTNM","BK4139","LENZ"],"gpt_icon":0},{"id":"2491374313","title":"Contineum Therapeutics, Inc.盘中异动 早盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491374313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491374313?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:42","pubTimestamp":1734104573,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时42分,Contineum Therapeutics, Inc.股票出现异动,股价快速跳水5.07%。Contineum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.48%。Contineum Therapeutics, Inc.公司简介:Contineum Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现和开发新型口服小分子疗法,用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213234253a1ec54be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213234253a1ec54be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","CTNM"],"gpt_icon":0},{"id":"2488976808","title":"Contineum Therapeutics, Inc.盘中异动 股价大跌5.42%报14.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488976808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488976808?lang=zh_cn&edition=full","pubTime":"2024-12-04 04:58","pubTimestamp":1733259481,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日04时58分,Contineum Therapeutics, Inc.股票出现异动,股价快速下挫5.42%。截至发稿,该股报14.32美元/股,成交量3.8298万股,换手率0.15%,振幅5.38%。Contineum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.07%。Contineum Therapeutics, Inc.公司简介:Contineum Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现和开发新型口服小分子疗法,用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204045802971b6e47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204045802971b6e47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTNM","LENZ","BK4007"],"gpt_icon":0},{"id":"2486030080","title":"Contineum Therapeutics, Inc.盘中异动 早盘急速拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486030080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486030080?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:35","pubTimestamp":1732545317,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时35分,Contineum Therapeutics, Inc.股票出现波动,股价急速上涨5.25%。Contineum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.10%。Contineum Therapeutics, Inc.公司简介:Contineum Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现和开发新型口服小分子疗法,用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223517abddfc12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223517abddfc12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CTNM","LENZ","BK4139"],"gpt_icon":0},{"id":"2484718346","title":"Contineum Therapeutics, Inc.盘中异动 早盘股价大跌5.35%报16.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484718346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484718346?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:00","pubTimestamp":1731942013,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时00分,Contineum Therapeutics, Inc.股票出现异动,股价大幅下挫5.35%。截至发稿,该股报16.29美元/股,成交量9081股,换手率0.04%,振幅5.14%。Contineum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.55%。Contineum Therapeutics, Inc.公司简介:Contineum Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现和开发新型口服小分子疗法,用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230014971a732c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230014971a732c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CTNM","BK4007"],"gpt_icon":0},{"id":"2483579688","title":"Contineum Therapeutics, Inc.盘中异动 股价大跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483579688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483579688?lang=zh_cn&edition=full","pubTime":"2024-11-14 04:43","pubTimestamp":1731530587,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日04时43分,Contineum Therapeutics, Inc.股票出现波动,股价急速下挫5.88%。Contineum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。Contineum Therapeutics, Inc.公司简介:Contineum Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现和开发新型口服小分子疗法,用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114044307abbe8f3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114044307abbe8f3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTNM","BK4007","LENZ"],"gpt_icon":0},{"id":"2481305841","title":"Contineum Therapeutics, Inc.盘中异动 下午盘快速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481305841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481305841?lang=zh_cn&edition=full","pubTime":"2024-11-08 02:49","pubTimestamp":1731005392,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日02时49分,Contineum Therapeutics, Inc.股票出现异动,股价大幅上涨5.19%。Contineum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.90%。Contineum Therapeutics, Inc.公司简介:Contineum Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现和开发新型口服小分子疗法,用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108024952a2216b13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108024952a2216b13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CTNM","BK4007"],"gpt_icon":0},{"id":"2481421839","title":"美国研究综述-BXP、Hubspot、高通公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2481421839","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481421839?lang=zh_cn&edition=full","pubTime":"2024-11-07 15:07","pubTimestamp":1730963275,"startTime":"0","endTime":"0","summary":"美国研究综述-BXP、Hubspot、高通公司路透11月7日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括 BXP、Hubspot 和高通公司。* Clearwater Analytics Holdings Inc CWAN.N:摩根大通将其评级从中性上调至增持 * Hubspot Inc HUBS.N:摩根大通将目标价从560美元上调至635美元 * 高通QCOM.O:摩根大通将目标价从 195 美元上调至 200 美元 以下是路透周四报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4S3ME0W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIZ","LU2125909593.SGD","CRL","APP","LNTH","HUBS","BMBL","BROS","HCAT","HLNE","JKHY","BK4223","FRSH","KVYO","ELF","LU1803068623.USD","EHTH","IE00B4R5TH58.HKD","GILD","LU1939255532.USD","CVS","GH","IDYA","CPNG","DAWN","ALB","BK4528","ARMK","NOG","LU0965509101.SGD","MRK","CTNM","GHLD","BXP","AZPN","EMR","CWAN","CRC","BK4516","IE00BJJMRZ35.SGD","LYFT","KRUS","LU1878469433.USD","ANSS","GPOR","DV","COR","CLOV","BK4194","IFF"],"gpt_icon":0},{"id":"2481156981","title":"Contineum Therapeutics, Inc.盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481156981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481156981?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:17","pubTimestamp":1730906271,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时17分,Contineum Therapeutics, Inc.股票出现波动,股价大幅上涨5.12%。Contineum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.28%。Contineum Therapeutics, Inc.公司简介:Contineum Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现和开发新型口服小分子疗法,用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106231752971a4d1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106231752971a4d1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CTNM","BK4007"],"gpt_icon":0},{"id":"2477463872","title":"美国研究综述-加拉帕戈斯, 马什和麦克莱南, 旅行者","url":"https://stock-news.laohu8.com/highlight/detail?id=2477463872","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477463872?lang=zh_cn&edition=full","pubTime":"2024-10-22 14:31","pubTimestamp":1729578683,"startTime":"0","endTime":"0","summary":" 路透10月22日 - 华尔街证券分析师周二调整了对 Galapagos、Marsh & Mclennan 和 Travelers 等多家美国上市公司的评级和目标价。* Applovin Corp :摩根大通将目标价从57美元上调至160美元 * BCB Bancorp Inc :KBW 将目标价从 13.25 美元上调至 13.5 美元 * Contineum Therapeutics Inc :贝雅将其评级定为 \"跑赢大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPG","NSP","LU0738911758.USD","LU0882574139.USD","BCBP","LU0211328371.USD","LU0061475181.USD","TRV","IE00BFMHRM44.USD","CTNM","LU0316494557.USD","BK4023","IE00BJTD4N35.SGD","LU2023250330.USD","ETSY","LU0943347566.SGD","LU0971096721.USD","BK4547","ZION","FITB","MCBS","GRDN","LU0820561818.USD","LU1003077747.HKD","PLXS","VSEC","GXO","LU0949170772.SGD","LU","SG9999015986.USD","LU1244550494.USD","LU1720051017.SGD","ENVX","WRB","MMC","ZETA","KMI","PRMW","APP","GLPG","MDLZ","BK4559","LU1244550221.USD","LU0149725797.USD","RBLX","DTE","BK4085","TTWO"],"gpt_icon":1},{"id":"2474205305","title":"Contineum Therapeutics, Inc.盘中异动 下午盘大幅下跌5.42%报16.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474205305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474205305?lang=zh_cn&edition=full","pubTime":"2024-10-10 03:13","pubTimestamp":1728501220,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日03时13分,Contineum Therapeutics, Inc.股票出现异动,股价快速下挫5.42%。Contineum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。Contineum Therapeutics, Inc.公司简介:Contineum Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现和开发新型口服小分子疗法,用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101003134098e3b864&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101003134098e3b864&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTNM","BK4139","BK4007"],"gpt_icon":0},{"id":"2472969725","title":"Contineum Therapeutics, Inc.盘中异动 快速跳水5.08%报16.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472969725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472969725?lang=zh_cn&edition=full","pubTime":"2024-10-04 23:49","pubTimestamp":1728056948,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日23时49分,Contineum Therapeutics, Inc.股票出现异动,股价大幅下挫5.08%。Contineum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.28%。Contineum Therapeutics, Inc.公司简介:Contineum Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现和开发新型口服小分子疗法,用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042349089719e6a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042349089719e6a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTNM","BK4007","BK4139"],"gpt_icon":0},{"id":"2459110671","title":"美国研究综述-Agenus、Guardant Health、Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2459110671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459110671?lang=zh_cn&edition=full","pubTime":"2024-08-14 14:49","pubTimestamp":1723618162,"startTime":"0","endTime":"0","summary":" 路透8月14日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括 Agenus、Guardant Health 和 Zoetis。要闻 * Agenus Inc :B. Riley将目标价从42美元下调至18美元 * Clorox :杰富瑞将目标价从 148 美元上调至 151 美元 * Guardant Health Inc :Raymond James将目标价从28美元上调至36美元 * 星巴克 :Stifel将其评级从 \"持有 \"上调至 \"买入\";将目标价从80美元上调至110美元 * Zoetis Inc :Piper Sandler将目标价从195美元上调至210美元 以下是路透周三报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BALL","EIX","FE","ETR","AWK","EXC","HD","FENC","ED","AMCX","AEP","ATKR","BHF","MO","BOLD","LU0149725797.USD","ALUR","FEMY","WTRG","LU","LU0205193047.USD","IBTA","LU2506952410.USD","EMR","IDXX","CPK","ADVM","CMS","ANNX","D","CLX","SLRN","ES","LU2211815571.USD","AIZ","CNP","DUK","AGEN","HEI","LU2506952337.HKD","LU1363072403.SGD","GH","BKH","LU0942090050.USD","FTHM","SKY","CTNM"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.contineum-tx.com","stockEarnings":[{"period":"1week","weight":0.0083},{"period":"1month","weight":0.0276},{"period":"3month","weight":-0.1459},{"period":"6month","weight":-0.2751},{"period":"1year","weight":-0.0925},{"period":"ytd","weight":-0.0089}],"compareEarnings":[{"period":"1week","weight":-0.0051},{"period":"1month","weight":-0.0259},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.2668},{"period":"ytd","weight":0.01}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Contineum Therapeutics, Inc.于2009年作为Versense Pharmaceuticals, Inc. (Versense)在特拉华州注册成立。2023年11月,公司更名为Contineum Therapeutics, Inc. 该公司是一家临床阶段的生物制药公司,专注于发现和开发具有高未满足需求的NI&I适应症的新型口服小分子疗法。他们针对与特定临床损伤相关的生物学途径,他们认为这些途径一旦得到调节,将明显改变疾病的进程。","exchange":"NASDAQ","name":"Contineum Therapeutics, INC.","nameEN":"Contineum Therapeutics, INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Contineum Therapeutics, INC.(CTNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Contineum Therapeutics, INC.(CTNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Contineum Therapeutics, INC.,CTNM,Contineum Therapeutics, INC.股票,Contineum Therapeutics, INC.股票老虎,Contineum Therapeutics, INC.股票老虎国际,Contineum Therapeutics, INC.行情,Contineum Therapeutics, INC.股票行情,Contineum Therapeutics, INC.股价,Contineum Therapeutics, INC.股市,Contineum Therapeutics, INC.股票价格,Contineum Therapeutics, INC.股票交易,Contineum Therapeutics, INC.股票购买,Contineum Therapeutics, INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Contineum Therapeutics, INC.(CTNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Contineum Therapeutics, INC.(CTNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}